An overview on recent patents and technologies on nanoparticles for nucleic acid delivery.
Larissa Moraes Dos Santos FonsecaBruna Aparecida Souza MachadoFabricia Oliveira OliveiraJânio Rodrigo de Jesus SantosJaqueline Wang da SilvaKatharine Valeria Saraiva HodelBrisa Gonçalves RosattiClaudio Damasceno PintoMilena Botelho Pereira SoaresPublished in: Expert opinion on therapeutic patents (2024)
Investment in NPs for nucleic acid delivery has significantly surged in recent years. However, translating these therapies into clinical practice faces obstacles, including the need for robust clinical evidence, regulatory compliance, and streamlined manufacturing processes. To address these challenges, our review article summarizes recent advances. We aim to engage researchers worldwide in the development of these promising technologies.